Curaleaf Launches New Plant Precision Product Line Expanding Portfolio in Health and Wellness Categories
Leading international provider of consumer products in cannabis Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) recently announced the launch of Plant Precision, a curated collection of edibles and a topical gel designed to target specific wellness categories.
Curaleaf believes the new Plant Precision line fills an area where consumer demand outweighs supply in the form of low dose THC formats geared towards everyday wellness. The company has provided survey data highlighting that nearly 3 out every 4 Americans would consider using cannabis for health and wellness purposes.
Curaleaf Cannabis Consumer Use Survey Data
The company cited a Curaleaf / Harris Poll survey noting 69% of Americans say they would be more likely to use cannabis as a health solution if it came in small, controlled doses.
Based on these findings, Curaleaf as an industry leader recognized the market need and created the new approachable line of cannabis products designed for a new wellness-oriented consumer.
Plant Precision offers gummy edibles with low, customizable doses of THC and high doses of non-psychoactive therapeutic minor cannabinoids like CBD, CBG, CBN and THCV, along with a fast-absorbing THC topical gel.
The survey was conducted online within the United States by The Harris Poll on behalf of Curaleaf from March 8-10, 2022, among 1,953 adults ages 21+, among whom 1,095 have never used cannabis.
The sampling precision of Harris online polls is measured by using a Bayesian credible interval. For this study, the sample data is accurate to within + 2.8 percentage points using a 95% confidence level. For complete survey methodology, including weighting variables and subgroup sample sizes, please contact firstname.lastname@example.org.
Full Poll Results can be found: HERE
About Plant Precision Cannabis Products
Plant Precision allows consumers to explore a range of potentially therapeutic destinations with a blend of products that highlight their focus.
For waking up, winding down, or offering a moment of calm, the Balance apple-flavored gummies include 2.5mg THC and 10mg CBD. The ideal cannabinoid profile.
The Slumber Gummies are a cherry-flavored cannabis gummy with 2.5mg total THC and 10mg CBN, which is often added to a nighttime regimen to help you fall (and stay) asleep.
For relaxation after travel, lengthy exercises, or long weekends, the Soothe Gummy is a pineapple-flavored cannabis edible with 2.5mg THC and 10mg CBG.
The lemon-flavored Boost gummy with 2.5mg THC and 10mg THCV is meant to give you a boost and start your day off on the right foot.
Relieve Topical Gel
A topical gel with 100% THC that targets tension and has a 30-minute to 45-minute onset period.
The Plant Precision Minor Cannabinoid Profile
Plant Precision gummies include minor cannabinoids that are non-psychoactive and do not create the euphoric feeling provided by THC, however they interact with human receptor systems in various ways and produce distinct biological outcomes.
The Plant Precision gummies use liposomal encapsulation, a process that surrounds the cannabinoid molecules with fatty acids, to help guarantee every milligram is utilized. Furthermore, each Plant Precision Gummy line has been designed using compounds from terpenes that work in tandem with THC to offer the entourage effect, which is a phenomenon in which minor cannabinoids interact with THC and produce an individual effect with possible therapeutic advantages.
The Plant Precision Topical Gel was designed with hydro-alcoholic technology to allow for the absorption of cannabinoids through the skin, and it contains 650mg of total THC – more than nearly all other marketed THC topicals with the company noting that topical THC levels are 650mg unless in a state where regulations have maximum THC rules such as Massachusetts.
Curaleaf Plant Precision Launch Plans
Plant Precision items will begin at Curaleaf dispensaries in 5 states now through August. The gummies and gel are available in, with the gel also available in Florida, Nevada and Utah with the full range of gummy availability dependent on the regulatory status of minor cannabinoids (CBD, CBG, CBN, THCV) by state.
The cannabis edibles are now available in gummy form in Arizona and Massachusetts along with the gel also being accessible in Florida, Nevada, and Utah. The full range of gummy availability is determined by the regulatory status of minor cannabinoids (CBD, CBG, CBN, THCV) in each state.
About Curaleaf Holdings
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) is a multinational company that offers consumer goods in cannabis with the goal of enhancing people’s lives by providing clarity and confidence around cannabis use.
The Company and its brands, including Curaleaf and Select, provide industry-leading service, product variety, and accessibility across the medical and adult-use markets as a high-growth cannabis business recognized for quality, knowledge, and dependability.
In the United States, Curaleaf has 28 locations across 22 states, with 134 dispensaries, 26 cultivation facilities, and over 5,700 team members.
The largest vertically integrated cannabis business in Europe is Curaleaf International, which combines pioneering research and development with cutting-edge cultivation, extraction, and manufacturing.
The firm trades on both the OTCQX market under CURLF and the Canadian Securities Exchange under CURA.